European Commission Desameta Trump and denies a link between paracetamol in pregnancy and autism

European Commission Desameta Trump and denies a link between paracetamol in pregnancy and autism


European Medicines Agency (EMA) said there is no scientific evidence that demonstrate the risk


Summary

The European Commission denied Donald Trump’s statements, reaffirming that there is no scientific tests of link between the use of paracetamol in pregnancy and autism, considering the safe drug for pregnant women.




After the president of the United States Donald Trump has associated the use of paracetamori in pregnancy with autism, the European Commission has declared that there is no scientific evidence that demonstrate the risk. In addition, according to the agency, use is safe for pregnant women.

“Paracetamol remains an important option for the treatment of pain or fever in pregnant women. Our recommendation is based on a rigorous evaluation of the available scientific data and we do not find evidence of the fact that the use of acetaminophen during pregnancy causes autism in children”, said the spokesman for the European Agency (Ema), Stefen ThirdStrup.

According to the declaration, in 2019, Ema revised available studies that studied the development of the neurods of children exposed to Acetamin in the uterus and concluded that the results were inconclusive and that no connection could be established with the neurodic development disorders.

What did Trump say?

On Monday 22, Trump said that the FDA of Anvisa (American equivalent) would have given a warning to health workers on an alleged increase in the risk of autism in children exposed to Paracetamol during pregnancy.

“Tylenol is not good. It’s not good,” the president repeated during a press conference, referring to the commercial name of the drug widely used in the US market. He declared that, from now on, the recommendation is that the use of pain reliever by pregnant women will occur only in the event of extreme need.

Competition of the manufacturer and medical entities

The substance is one of the most common in the treatment of light pain and fever and historically is considered safe for pregnant women. However, the debate on its effects on fetal neurological development has intensified, although there is no scientific consensus on any direct relationship with the autistic spectrum.

In the United States, the drug is produced by Kenvue, a company that separated from Johnson & Johnson in 2023. The pharmacist reacted to Trump’s declaration stating that there is no scientific support for the presidential accusations.

The medical entities also contested the position. The American College of OBSTETRICS and Gynecology has reiterated that the studies available so far have no direct association between the responsible use of Paracetamol at any phase of pregnancy and changes in fetal development.

In the United Kingdom, the National Health Service (NHS) maintains the drug as the main analgesic recommendation for pregnant women, highlighting its safety in controlled use. “It is commonly taken during pregnancy and does not hurt the child”, according to the British authority.

Source: Terra

You may also like